Current Edition

Abexinostat

Xynomic Pharma Plans 4 Clinical Trials of Abexinostat for Lymphoma

 Xynomic Pharma announced it has completed a new Series B financing round and now will initiate eight clinical trials, four of which are for different types of …

Continue Reading →